<DOC>
	<DOCNO>NCT02531724</DOCNO>
	<brief_summary>Acute kidney injury ( AKI ) common complication cardiac surgery . Mismatch renal oxygen demand-supply may important pathogenetic factor . Levosimendan show improve renal blood flow , glomerular filtration rate renal oxygenation healthy control cardiac surgery . In order investigate effect levosimendan patient AKI cardiac surgery , investigator plan randomize placebo control trial . 30 patient receive levosimendan placebo . Renal blood flow filtration fraction measure use infusion clearance technique para-aminohippuric acid Chromium ethylenediaminetetraacetic acid ( Cr-EDTA ) respectively .</brief_summary>
	<brief_title>Effects Levosimendan Acute Kidney Injury After Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Simendan</mesh_term>
	<criteria>Patients cardiothoracic intensive care cardiac surgery cardiopulmonary bypass Acute kidney injury , define increase Screatinine 50 % 27 mol/L Normal Screatinine surgery Ongoing treatment inotropic drug ( norepinephrine ) Central venous oxygen saturation ( ScvO2 ) &lt; 60 % despite optimization hematocrit volume status Need renal replacement therapy Ongoing bleeding Patient next kin consent study participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>acute kidney injury</keyword>
	<keyword>cardiac surgery</keyword>
	<keyword>renal blood flow</keyword>
	<keyword>levosimendan</keyword>
</DOC>